Market Research Report
North America Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027
|North America Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027|
Published: October 1, 2020
Data Bridge Market Research Private Limited
Content info: 100 Pages
Delivery time: Inquiry
North America alopecia treatment (hair loss) market is projected to register a CAGR of 5.4% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
North America Alopecia Treatment (Hair Loss) Market, By Disease Type (Non-Cicatricial Alopecia, Traction Alopecia, Ciatricial Alopecia, Others), Treatment (Localized Therapies, Medical Devices, Systemic Therapies, Herbal Treatment), Gender (Male, Female), Form (Topical, Oral, Parenteral), End User (Dermatology Centers, Hospitals, Home Healthcare), Distribution Channel (Pharmacies, Retail Sales, Direct Tender), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2027
Technological advancements in hair treatment medical devices
Increase in prevalence of chemotherapy induced alopecia
Lexington Intl., LLC.
Freedom Laser Therapy, Inc.
Taisho Pharmaceutical Holdings Co., Ltd.
Vita-Cos-Med Klett-Loch GmbH
Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceuticals Industries Ltd.)
Par Pharmaceutical (A Subsidiary of Endo International plc)
Dr. Reddy's Laboratories Ltd.
Zydus Pharmaceuticals, Inc. (A subsidiary of Zydus Cadila)
Johnson & Johnson Services, Inc
Sun Pharmaceutical Industries Ltd.
Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc.
Perrigo Company plc
Viviscal Limited (A Subsidiary of Church & Dwight Co.)
Dr. Kurt Wolff GmbH & Co. KG
Labo International S.r.l.
WON TECH Co., Ltd.